Total Payments
$526.78
2022 Payments
$17.07
Companies
7
Transactions
19
Medicare Patients
16,511
Medicare Billing
$2.4M
Payment Breakdown by Category
Food & Beverage$526.78 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $526.78 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $281.98 | 6 | $0 (2021) |
| BRACCO DIAGNOSTICS INC. | $63.31 | 4 | $0 (2018) |
| Astellas Pharma US Inc | $63.08 | 2 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $62.34 | 3 | $0 (2019) |
| Lundbeck LLC | $24.38 | 2 | $0 (2018) |
| HeartFlow, Inc. | $17.07 | 1 | $0 (2022) |
| Amgen Inc. | $14.62 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $17.07 | 1 | HeartFlow, Inc. ($17.07) |
| 2021 | $148.95 | 1 | Abbott Laboratories ($148.95) |
| 2019 | $62.34 | 3 | Actelion Pharmaceuticals US, Inc. ($62.34) |
| 2018 | $186.95 | 9 | Abbott Laboratories ($133.03) |
| 2017 | $111.47 | 5 | Astellas Pharma US Inc ($63.08) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2022 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $17.07 | General |
| Category: Coronary | ||||||
| 06/18/2021 | Abbott Laboratories | MitraClip System (Device) | Food and Beverage | In-kind items and services | $148.95 | General |
| Category: Structural Heart | ||||||
| 11/07/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Cardiology | ||||||
| 08/21/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Cardiology | ||||||
| 04/15/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Cardiology | ||||||
| 11/19/2018 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $43.73 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 10/22/2018 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $12.44 | General |
| Category: NEUROLOGY | ||||||
| 10/06/2018 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Vascular | ||||||
| 07/18/2018 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $11.94 | General |
| Category: NEUROLOGY | ||||||
| 06/05/2018 | Abbott Laboratories | Fortify Assura, Ellipse ICD (Device) | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 05/29/2018 | BRACCO DIAGNOSTICS INC. | CARDIOGEN (Drug) | Food and Beverage | Cash or cash equivalent | $26.70 | General |
| Category: CONTRAST MEDIA | ||||||
| 05/29/2018 | BRACCO DIAGNOSTICS INC. | CARDIOGEN (Drug) | Food and Beverage | Cash or cash equivalent | $2.84 | General |
| Category: CONTRAST MEDIA | ||||||
| 03/09/2018 | Abbott Laboratories | ICDs (Device) | Food and Beverage | In-kind items and services | $40.30 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/28/2018 | Abbott Laboratories | Circulatory Support (Device) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/12/2017 | BRACCO DIAGNOSTICS INC. | ISOVUE (Drug) | Food and Beverage | Cash or cash equivalent | $14.36 | General |
| Category: CONTRAST MEDIA | ||||||
| 10/24/2017 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $44.84 | General |
| 09/05/2017 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Cardiology | ||||||
| 02/07/2017 | Astellas Pharma US Inc | Lexiscan (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Cardiology | ||||||
| 01/26/2017 | BRACCO DIAGNOSTICS INC. | ISOVUE (Drug) | Food and Beverage | Cash or cash equivalent | $19.41 | General |
| Category: CONTRAST MEDIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 4,788 | 6,890 | $3.0M | $804,772 |
| 2022 | 29 | 4,270 | 6,110 | $2.2M | $648,439 |
| 2021 | 30 | 4,184 | 6,148 | $1.8M | $584,153 |
| 2020 | 30 | 3,269 | 4,700 | $1.3M | $390,523 |
Total Patients
16,511
Total Services
23,848
Medicare Billing
$2.4M
Procedure Codes
119
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 98 | 98 | $656,600 | $160,783 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 761 | 1,209 | $435,240 | $137,170 | 31.5% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 89 | 89 | $321,735 | $109,876 | 34.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 487 | 488 | $497,760 | $85,734 | 17.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 228 | 305 | $149,740 | $50,330 | 33.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 193 | 776 | $97,000 | $32,930 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 338 | 365 | $89,740 | $28,587 | 31.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 142 | 226 | $63,780 | $24,984 | 39.2% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 185 | 257 | $34,646 | $24,960 | 72.0% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 185 | 187 | $57,595 | $23,758 | 41.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,065 | 1,662 | $166,200 | $21,432 | 12.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 94 | 99 | $51,105 | $15,469 | 30.3% |
| G0423 | Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | Office | 2023 | 47 | 136 | $51,435 | $15,131 | 29.4% |
| G0422 | Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | Office | 2023 | 47 | 130 | $49,225 | $14,464 | 29.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 226 | 229 | $97,325 | $14,420 | 14.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 23 | 23 | $40,250 | $9,847 | 24.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 22 | 22 | $11,550 | $8,629 | 74.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $23,240 | $6,918 | 29.8% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 83 | 94 | $59,380 | $5,575 | 9.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $7,540 | $2,149 | 28.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 84 | 95 | $9,975 | $2,064 | 20.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 95 | 98 | $14,210 | $1,970 | 13.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 26 | $5,150 | $1,920 | 37.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 22 | 22 | $5,610 | $1,509 | 26.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 54 | 54 | $7,290 | $1,381 | 18.9% |
About Dr. Christopher Cesa, M.D
Dr. Christopher Cesa, M.D is a Cardiovascular Disease healthcare provider based in East Setauket, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083661458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Cesa, M.D has received a total of $526.78 in payments from pharmaceutical and medical device companies, with $17.07 received in 2022. These payments were reported across 19 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($526.78).
As a Medicare-enrolled provider, Cesa has provided services to 16,511 Medicare beneficiaries, totaling 23,848 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location East Setauket, NY
- Active Since 05/30/2006
- Last Updated 04/29/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1083661458
Products in Payments
- MitraClip System (Device) $148.95
- UPTRAVI (Drug) $62.34
- Confirm Rx (Device) $43.73
- ICDs (Device) $40.30
- ISOVUE (Drug) $33.77
- CARDIOGEN (Drug) $29.54
- Circulatory Support (Device) $24.48
- NORTHERA (Drug) $24.38
- Lexiscan (Drug) $18.24
- Mitra Clip system (Device) $17.81
- FFRct (Device) $17.07
- Corlanor (Drug) $14.62
- Fortify Assura, Ellipse ICD (Device) $6.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in East Setauket
Dr. Michael Matilsky, M.d, M.D
Cardiovascular Disease — Payments: $254,905
Cardiovascular Disease $254,905
Dr. Mark Borek, M.d, M.D
Cardiovascular Disease — Payments: $12,551
Cardiovascular Disease $12,551
Dr. David Shenouda, D.o, D.O
Cardiovascular Disease — Payments: $11,336
Cardiovascular Disease $11,336
Dr. David Benson, Md, MD
Cardiovascular Disease — Payments: $3,885
Cardiovascular Disease $3,885
Dr. Neal Patel, M.d, M.D
Cardiovascular Disease — Payments: $2,373
Cardiovascular Disease $2,373
Shug-Hong Young, M.d, M.D
Cardiovascular Disease — Payments: $2,371
Cardiovascular Disease $2,371